查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1446394

热原测试市场：按产品和服务、按测试类型、按最终用户：2023-2032 年全球机会分析和产业预测

Pyrogen Testing Market By Product and Service, By Test Type, By End User : Global Opportunity Analysis and Industry Forecast, 2023-2032
出版日期: | 出版商: Allied Market Research | 英文 286 Pages | 商品交期: 2-3个工作天内

价格
热原测试市场-IMG1

热原测试包括使用细菌衍生物质的体外方法，例如鲎阿米巴细胞裂解物（LAL）测试，该测试通常用于检测内毒素。

其他方法包括单核细胞活化试验 (MAT) 和兔热原试验，但由于伦理问题以及更特异性的替代方法的存在，这些方法不太常用。热原测试的目的是透过防止接触可能损害患者健康的热原污染物来确保医疗产品的安全和品质。

推动热原测试市场成长的主要因素包括人们越来越重视确保药品和医疗设备的安全和质量，以及心臟病、糖尿病、关节炎、癌症、糖尿病等慢性疾病的流行。医疗费率急剧上升以及对药品和医疗设备的需求增加。製药和生物技术行业先进配方的开拓是热原测试市场扩张的关键驱动力。药品日益复杂，需要实施更多的品管措施，从而导致热原测试的采用。此外，越来越多的製药和生物技术行业采用复杂的配方和尖端的医疗技术，增加了对先进、灵敏的热原测试方法的需求，这正在推动市场成长。

此外，越来越多的减少热原污染的倡议促使全球监管机构和医疗机构制定了严格的标准。这使得必须采用强大的热原测试方法，从而促进热原测试市场的成长。例如，美国食品药物管理局（FDA）和欧洲药品管理局（EMA）等监管机构制定了明确的热原检测指南和标准。这些指南概述了药品和医疗设备製造商进行彻底的热原测试作为其品管过程的一部分的监管期望和要求。因此，严格遵守这些准则将极大地促进市场成长。

此外，热原测试技术的不断进步将进一步推动市场成长。体外方法和测试、内毒素测试和重组 C 因子测定等创新热原检测方法的发展正在提高热原测试过程的准确性和效率。例如，Lonza Group 生产 PyroTec PRO，这是一种自动化内毒素检测平台，采用先进技术来提高热原检测的效率和准确性。该系统利用已建立的鲎变形细胞裂解物 (LAL) 测试方法来自动化和简化测试过程。这些技术进步使製药商能够采用更可靠、更快速的测试程序，推动市场成长。

然而，热原测试的标准化有限阻碍了市场的成长。此外，缺乏有关热原污染风险和测试方法的知识和教育，阻碍了热原测试在新兴地区的普及。相较之下，以创新和产品开发为重点的医疗设备产业的扩张以及新兴国家的高成长潜力预计将在预测期内提供利润丰厚的机会。

热原测试市场按产品/服务、测试类型、最终用户和地区进行细分。依产品和服务，市场分为试剂和套件、设备和服务。依试验类型分为鲎试剂试验、兔热原试验等。按最终用户划分，它们分为製药/生技公司、医疗设备公司等。按地区划分，我们有北美（美国、加拿大、墨西哥）、欧洲（德国、英国、英国、义大利、西班牙其他欧洲国家地区）、亚太地区（日本、中国、澳洲、印度、韩国、其他亚太地区）、洛杉矶（巴西、哥伦比亚、阿根廷和其他亚太地区）和MEA（海湾合作委员会、南美、北非和其他MEA 地区）进行了分析。

相关人员的主要利益

  • 本报告定量分析了 2022 年至 2032 年热原测试市场分析的细分市场、当前趋势、估计/趋势和动态，并确定了热原测试市场的强大机会。
  • 我们提供市场研究以及与市场驱动因素、市场限制和市场机会相关的资讯。
  • 波特的五力分析强调买家和供应商帮助相关人员做出以利润为导向的商业决策并加强供应商-买家网路的潜力。
  • 对热原测试市场细分的详细分析有助于识别市场机会。
  • 每个地区的主要国家都根据其对全球市场的收益贡献绘製了地图。
  • 市场公司定位有助于基准化分析并提供对市场公司当前地位的清晰了解。
  • 该报告包括对区域和全球热原测试市场趋势、主要企业、细分市场、应用领域和市场成长策略的分析。

相关人员的主要利益

  • 本报告定量分析了 2022 年至 2032 年热原测试市场分析的细分市场、当前趋势、估计/趋势和动态，并确定了热原测试市场的强大机会。
  • 我们提供市场研究以及与市场驱动因素、市场限制和市场机会相关的资讯。
  • 波特的五力分析强调买家和供应商帮助相关人员做出以利润为导向的商业决策并加强供应商-买家网路的潜力。
  • 对热原测试市场细分的详细分析有助于识别市场机会。
  • 每个地区的主要国家都根据其对全球市场的收益贡献绘製了地图。
  • 市场公司定位有助于基准化分析并提供对市场公司当前地位的清晰了解。
  • 该报告包括对区域和全球热原测试市场趋势、主要企业、细分市场、应用领域和市场成长策略的分析。

可使用此报告进行客製化（需要额外费用和时间表）

  • 监管指引
  • 根据客户兴趣加入公司简介
  • 按国家或地区进行的附加分析 – 市场规模和预测
  • 公司简介的扩充列表
  • 历史市场资料
  • 主要企业详细资料（Excel 格式，包括位置、联络资讯、供应商/供应商网路等）

目录

第一章简介

第 2 章执行摘要

第三章市场概况

  • 市场定义和范围
  • 主要发现
    • 影响因素
    • 主要投资机会
  • 波特五力分析
  • 市场动态
    • 促进因素
    • 抑制因素
    • 机会

第四章热原测试市场：依产品/服务分类

  • 概述
  • 试剂和套件
  • 检验设备
  • 服务

第五章热原测试市场：依测试类型

  • 概述
  • 鲎试剂检验
  • 兔热原测试（RPT）
  • 其他的

第六章热原测试市场：依最终用户分类

  • 概述
  • 製药和生物技术公司
  • 医疗设备公司
  • 其他的

第七章热原测试市场：按地区

  • 概述
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 其他的
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 其他的
  • 拉丁美洲
    • 巴西
    • 哥伦比亚
    • 阿根廷
    • 其他拉丁美洲
  • 中东/非洲
    • Gcc
    • 南非
    • 北非
    • 其他的

第八章 竞争格局

  • 介绍
  • 关键成功策略
  • 10家主要企业产品图谱
  • 竞争对手仪表板
  • 竞争热图
  • 2022年主要企业定位

第九章 公司简介

  • Lonza Group AG
  • Thermo Fisher Scientific Inc.
  • Fujifilm Holdings Corporation
  • GenScript
  • SEIKAGAKU CORPORATION
  • Charles River Laboratories
  • STERIS plc
  • Wuxi AppTec
  • Eurofins Scientific SE
  • Merck KGaA
Product Code: A00669
Pyrogen Testing Market - IMG1

Pyrogen testing involves in vitro methods using substances derived from bacterial sources, such as the Limulus amebocyte lysate (LAL) test, which is commonly employed for endotoxin detection. Other methods include the monocyte activation test (MAT) and rabbit pyrogen test, although these are less commonly used due to ethical concerns and the availability of more sensitive and specific alternatives. The goal of pyrogen testing is to ensure the safety and quality of medical products by preventing exposure to pyrogenic contaminants that could compromise patient health.

Key factors that drive the growth of the pyrogen testing market include a rise in emphasis on ensuring the safety and quality of pharmaceutical and medical devices, surge in the prevalence of chronic diseases, such as heart disease, diabetes, arthritis, cancer, & diabetes, and rise in demand for pharmaceuticals & medical devices. The development of advanced formulations in the pharmaceutical and biotechnology industries is a significant driver for the pyrogen testing market expansion. The increase in complexity of pharmaceutical products has necessitated the implementation of more quality control measures, leading to the adoption of pyrogen testing. In addition, the rise in number of pharmaceutical & biotechnology industries introducing complex formulations and cutting-edge medical technologies have led to the need for advanced and sensitive pyrogen testing methodologies, which propel the market growth.

Furthermore, growing initiatives for minimizing pyrogen contamination have led to global regulatory bodies and healthcare organizations to set strict standards. This mandates the adoption of strong pyrogen testing methods, contributing to the growth of the pyrogen testing market. For instance, regulatory authorities, such as the U.S. Food and Drug Administration (FDA), the European Medicines Agency (EMA), and others, have established clear guidelines and standards for pyrogen testing. These guidelines outline the regulatory expectations and requirements for pharmaceutical and medical device manufacturers to conduct thorough pyrogen testing as part of their quality control processes. Thus, stringent adherence to these guidelines contributes significantly to market growth.

Moreover, the rise in technological advancements in pyrogen testing further boosts market growth. The development of innovative pyrogen detection methods, such as in vitro and in vivo testing, endotoxin testing, and recombinant factor C assays, enhances the accuracy and efficiency of pyrogen testing processes. For instance, Lonza Group company manufacture PyroTec PRO, an automated endotoxin testing platform that incorporates advanced technology to enhance the efficiency and accuracy of pyrogen testing. The system utilizes the well-established Limulus Amoebocyte Lysate (LAL) test method automates and streamlines the testing process. These technological advancements enable pharmaceutical manufacturers to adopt more reliable and rapid testing procedures, thereby propelling the market growth.

However, limited standardization for pyrogen testing hinders market growth. In addition, lack of knowledge and education about pyrogen contamination risks and testing methodologies hinder the widespread adoption of pyrogen testing in emerging regions. In contrast, expanding the medical device industry, with a focus on innovation and product development, and high growth potential in emerging countries are expected to provide lucrative opportunities during the forecast period.

The pyrogen testing market is segmented on the basis of product & service, test type, end user, and region. By product & service, the market is classified into reagents & kits, instruments, and services. By test type, the market is divided into LAL tests, rabbit pyrogen test, and others. By end user, it is segregated into pharmaceutical & biotechnology companies, medical device companies, and others. Region-wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), LA (Brazil, Colombia, Argentina, and rest of LA), and MEA (GCC, South Africa, North Africa, and rest of MEA).

Major key players that operate in the pyrogen testing market are Merck KGaA, Lonza Group, Thermo Fisher Scientific Inc., FUJIFILM Holdings Corporation, GenScript, SEIKAGAKU CORPORATION, Charles River Laboratories, STERIS, WuXi AppTec, and Eurofins Scientific. Key players have adopted product launch as a key developmental strategy to improve the product portfolio of the pyrogen testing market. For instance, in August 2023, Lonza Group launched the Nebula Absorbance Reader, a new absorbance microplate reader which joins the company's portfolio of optimized instruments for streamlined endotoxin and pyrogen testing.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the pyrogen testing market analysis from 2022 to 2032 to identify the prevailing pyrogen testing market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the pyrogen testing market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global pyrogen testing market trends, key players, market segments, application areas, and market growth strategies.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the pyrogen testing market analysis from 2022 to 2032 to identify the prevailing pyrogen testing market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the pyrogen testing market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global pyrogen testing market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Expanded list for Company Profiles
  • Historic market data
  • Key player details (including location, contact details, supplier/vendor network etc. in excel format)

Key Market Segments

By Product and Service

  • Reagents and Kits
  • Instruments
  • Services

By Test Type

  • LAL Test
  • Rabbit Pyrogen Test
  • Others

By End User

  • Pharmaceutical and Biotechnology Companies
  • Medical Device Companies
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Colombia
    • Argentina
    • Rest Of La
  • Middle East and Africa
    • Gcc
    • South Africa
    • North Africa
    • Rest Of Mea

Key Market Players:

    • Lonza Group AG
    • Thermo Fisher Scientific Inc.
    • Fujifilm Holdings Corporation
    • GenScript
    • SEIKAGAKU CORPORATION
    • Charles River Laboratories
    • STERIS plc
    • Wuxi AppTec
    • Eurofins Scientific SE
    • Merck KGaA

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

  • 1.1. Report description
  • 1.2. Key market segments
  • 1.3. Key benefits to the stakeholders
  • 1.4. Research methodology
    • 1.4.1. Primary research
    • 1.4.2. Secondary research
    • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

  • 2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

  • 3.1. Market definition and scope
  • 3.2. Key findings
    • 3.2.1. Top impacting factors
    • 3.2.2. Top investment pockets
  • 3.3. Porter's five forces analysis
    • 3.3.1. Low bargaining power of suppliers
    • 3.3.2. Low threat of new entrants
    • 3.3.3. Low threat of substitutes
    • 3.3.4. Low intensity of rivalry
    • 3.3.5. Low bargaining power of buyers
  • 3.4. Market dynamics
    • 3.4.1. Drivers
    • 3.4.2. Restraints
    • 3.4.3. Opportunities

CHAPTER 4: PYROGEN TESTING MARKET, BY PRODUCT AND SERVICE

  • 4.1. Overview
    • 4.1.1. Market size and forecast
  • 4.2. Reagents and Kits
    • 4.2.1. Key market trends, growth factors and opportunities
    • 4.2.2. Market size and forecast, by region
    • 4.2.3. Market share analysis by country
  • 4.3. Instruments
    • 4.3.1. Key market trends, growth factors and opportunities
    • 4.3.2. Market size and forecast, by region
    • 4.3.3. Market share analysis by country
  • 4.4. Services
    • 4.4.1. Key market trends, growth factors and opportunities
    • 4.4.2. Market size and forecast, by region
    • 4.4.3. Market share analysis by country

CHAPTER 5: PYROGEN TESTING MARKET, BY TEST TYPE

  • 5.1. Overview
    • 5.1.1. Market size and forecast
  • 5.2. LAL Test
    • 5.2.1. Key market trends, growth factors and opportunities
    • 5.2.2. Market size and forecast, by region
    • 5.2.3. Market share analysis by country
  • 5.3. Rabbit Pyrogen Test
    • 5.3.1. Key market trends, growth factors and opportunities
    • 5.3.2. Market size and forecast, by region
    • 5.3.3. Market share analysis by country
  • 5.4. Others
    • 5.4.1. Key market trends, growth factors and opportunities
    • 5.4.2. Market size and forecast, by region
    • 5.4.3. Market share analysis by country

CHAPTER 6: PYROGEN TESTING MARKET, BY END USER

  • 6.1. Overview
    • 6.1.1. Market size and forecast
  • 6.2. Pharmaceutical and Biotechnology Companies
    • 6.2.1. Key market trends, growth factors and opportunities
    • 6.2.2. Market size and forecast, by region
    • 6.2.3. Market share analysis by country
  • 6.3. Medical Device Companies
    • 6.3.1. Key market trends, growth factors and opportunities
    • 6.3.2. Market size and forecast, by region
    • 6.3.3. Market share analysis by country
  • 6.4. Others
    • 6.4.1. Key market trends, growth factors and opportunities
    • 6.4.2. Market size and forecast, by region
    • 6.4.3. Market share analysis by country

CHAPTER 7: PYROGEN TESTING MARKET, BY REGION

  • 7.1. Overview
    • 7.1.1. Market size and forecast By Region
  • 7.2. North America
    • 7.2.1. Key market trends, growth factors and opportunities
    • 7.2.2. Market size and forecast, by Product and Service
    • 7.2.3. Market size and forecast, by Test Type
    • 7.2.4. Market size and forecast, by End User
    • 7.2.5. Market size and forecast, by country
      • 7.2.5.1. U.S.
      • 7.2.5.1.1. Market size and forecast, by Product and Service
      • 7.2.5.1.2. Market size and forecast, by Test Type
      • 7.2.5.1.3. Market size and forecast, by End User
      • 7.2.5.2. Canada
      • 7.2.5.2.1. Market size and forecast, by Product and Service
      • 7.2.5.2.2. Market size and forecast, by Test Type
      • 7.2.5.2.3. Market size and forecast, by End User
      • 7.2.5.3. Mexico
      • 7.2.5.3.1. Market size and forecast, by Product and Service
      • 7.2.5.3.2. Market size and forecast, by Test Type
      • 7.2.5.3.3. Market size and forecast, by End User
  • 7.3. Europe
    • 7.3.1. Key market trends, growth factors and opportunities
    • 7.3.2. Market size and forecast, by Product and Service
    • 7.3.3. Market size and forecast, by Test Type
    • 7.3.4. Market size and forecast, by End User
    • 7.3.5. Market size and forecast, by country
      • 7.3.5.1. Germany
      • 7.3.5.1.1. Market size and forecast, by Product and Service
      • 7.3.5.1.2. Market size and forecast, by Test Type
      • 7.3.5.1.3. Market size and forecast, by End User
      • 7.3.5.2. France
      • 7.3.5.2.1. Market size and forecast, by Product and Service
      • 7.3.5.2.2. Market size and forecast, by Test Type
      • 7.3.5.2.3. Market size and forecast, by End User
      • 7.3.5.3. UK
      • 7.3.5.3.1. Market size and forecast, by Product and Service
      • 7.3.5.3.2. Market size and forecast, by Test Type
      • 7.3.5.3.3. Market size and forecast, by End User
      • 7.3.5.4. Italy
      • 7.3.5.4.1. Market size and forecast, by Product and Service
      • 7.3.5.4.2. Market size and forecast, by Test Type
      • 7.3.5.4.3. Market size and forecast, by End User
      • 7.3.5.5. Spain
      • 7.3.5.5.1. Market size and forecast, by Product and Service
      • 7.3.5.5.2. Market size and forecast, by Test Type
      • 7.3.5.5.3. Market size and forecast, by End User
      • 7.3.5.6. Rest of Europe
      • 7.3.5.6.1. Market size and forecast, by Product and Service
      • 7.3.5.6.2. Market size and forecast, by Test Type
      • 7.3.5.6.3. Market size and forecast, by End User
  • 7.4. Asia-Pacific
    • 7.4.1. Key market trends, growth factors and opportunities
    • 7.4.2. Market size and forecast, by Product and Service
    • 7.4.3. Market size and forecast, by Test Type
    • 7.4.4. Market size and forecast, by End User
    • 7.4.5. Market size and forecast, by country
      • 7.4.5.1. Japan
      • 7.4.5.1.1. Market size and forecast, by Product and Service
      • 7.4.5.1.2. Market size and forecast, by Test Type
      • 7.4.5.1.3. Market size and forecast, by End User
      • 7.4.5.2. China
      • 7.4.5.2.1. Market size and forecast, by Product and Service
      • 7.4.5.2.2. Market size and forecast, by Test Type
      • 7.4.5.2.3. Market size and forecast, by End User
      • 7.4.5.3. India
      • 7.4.5.3.1. Market size and forecast, by Product and Service
      • 7.4.5.3.2. Market size and forecast, by Test Type
      • 7.4.5.3.3. Market size and forecast, by End User
      • 7.4.5.4. Australia
      • 7.4.5.4.1. Market size and forecast, by Product and Service
      • 7.4.5.4.2. Market size and forecast, by Test Type
      • 7.4.5.4.3. Market size and forecast, by End User
      • 7.4.5.5. South Korea
      • 7.4.5.5.1. Market size and forecast, by Product and Service
      • 7.4.5.5.2. Market size and forecast, by Test Type
      • 7.4.5.5.3. Market size and forecast, by End User
      • 7.4.5.6. Rest of Asia-Pacific
      • 7.4.5.6.1. Market size and forecast, by Product and Service
      • 7.4.5.6.2. Market size and forecast, by Test Type
      • 7.4.5.6.3. Market size and forecast, by End User
  • 7.5. Latin America
    • 7.5.1. Key market trends, growth factors and opportunities
    • 7.5.2. Market size and forecast, by Product and Service
    • 7.5.3. Market size and forecast, by Test Type
    • 7.5.4. Market size and forecast, by End User
    • 7.5.5. Market size and forecast, by country
      • 7.5.5.1. Brazil
      • 7.5.5.1.1. Market size and forecast, by Product and Service
      • 7.5.5.1.2. Market size and forecast, by Test Type
      • 7.5.5.1.3. Market size and forecast, by End User
      • 7.5.5.2. Colombia
      • 7.5.5.2.1. Market size and forecast, by Product and Service
      • 7.5.5.2.2. Market size and forecast, by Test Type
      • 7.5.5.2.3. Market size and forecast, by End User
      • 7.5.5.3. Argentina
      • 7.5.5.3.1. Market size and forecast, by Product and Service
      • 7.5.5.3.2. Market size and forecast, by Test Type
      • 7.5.5.3.3. Market size and forecast, by End User
      • 7.5.5.4. Rest Of La
      • 7.5.5.4.1. Market size and forecast, by Product and Service
      • 7.5.5.4.2. Market size and forecast, by Test Type
      • 7.5.5.4.3. Market size and forecast, by End User
  • 7.6. Middle East and Africa
    • 7.6.1. Key market trends, growth factors and opportunities
    • 7.6.2. Market size and forecast, by Product and Service
    • 7.6.3. Market size and forecast, by Test Type
    • 7.6.4. Market size and forecast, by End User
    • 7.6.5. Market size and forecast, by country
      • 7.6.5.1. Gcc
      • 7.6.5.1.1. Market size and forecast, by Product and Service
      • 7.6.5.1.2. Market size and forecast, by Test Type
      • 7.6.5.1.3. Market size and forecast, by End User
      • 7.6.5.2. South Africa
      • 7.6.5.2.1. Market size and forecast, by Product and Service
      • 7.6.5.2.2. Market size and forecast, by Test Type
      • 7.6.5.2.3. Market size and forecast, by End User
      • 7.6.5.3. North Africa
      • 7.6.5.3.1. Market size and forecast, by Product and Service
      • 7.6.5.3.2. Market size and forecast, by Test Type
      • 7.6.5.3.3. Market size and forecast, by End User
      • 7.6.5.4. Rest Of Mea
      • 7.6.5.4.1. Market size and forecast, by Product and Service
      • 7.6.5.4.2. Market size and forecast, by Test Type
      • 7.6.5.4.3. Market size and forecast, by End User

CHAPTER 8: COMPETITIVE LANDSCAPE

  • 8.1. Introduction
  • 8.2. Top winning strategies
  • 8.3. Product mapping of top 10 player
  • 8.4. Competitive dashboard
  • 8.5. Competitive heatmap
  • 8.6. Top player positioning, 2022

CHAPTER 9: COMPANY PROFILES

  • 9.1. Lonza Group AG
    • 9.1.1. Company overview
    • 9.1.2. Key executives
    • 9.1.3. Company snapshot
    • 9.1.4. Operating business segments
    • 9.1.5. Product portfolio
    • 9.1.6. Business performance
    • 9.1.7. Key strategic moves and developments
  • 9.2. Thermo Fisher Scientific Inc.
    • 9.2.1. Company overview
    • 9.2.2. Key executives
    • 9.2.3. Company snapshot
    • 9.2.4. Operating business segments
    • 9.2.5. Product portfolio
    • 9.2.6. Business performance
    • 9.2.7. Key strategic moves and developments
  • 9.3. Fujifilm Holdings Corporation
    • 9.3.1. Company overview
    • 9.3.2. Key executives
    • 9.3.3. Company snapshot
    • 9.3.4. Operating business segments
    • 9.3.5. Product portfolio
    • 9.3.6. Business performance
    • 9.3.7. Key strategic moves and developments
  • 9.4. GenScript
    • 9.4.1. Company overview
    • 9.4.2. Key executives
    • 9.4.3. Company snapshot
    • 9.4.4. Operating business segments
    • 9.4.5. Product portfolio
    • 9.4.6. Business performance
    • 9.4.7. Key strategic moves and developments
  • 9.5. SEIKAGAKU CORPORATION
    • 9.5.1. Company overview
    • 9.5.2. Key executives
    • 9.5.3. Company snapshot
    • 9.5.4. Operating business segments
    • 9.5.5. Product portfolio
    • 9.5.6. Business performance
    • 9.5.7. Key strategic moves and developments
  • 9.6. Charles River Laboratories
    • 9.6.1. Company overview
    • 9.6.2. Key executives
    • 9.6.3. Company snapshot
    • 9.6.4. Operating business segments
    • 9.6.5. Product portfolio
    • 9.6.6. Business performance
    • 9.6.7. Key strategic moves and developments
  • 9.7. STERIS plc
    • 9.7.1. Company overview
    • 9.7.2. Key executives
    • 9.7.3. Company snapshot
    • 9.7.4. Operating business segments
    • 9.7.5. Product portfolio
    • 9.7.6. Business performance
    • 9.7.7. Key strategic moves and developments
  • 9.8. Wuxi AppTec
    • 9.8.1. Company overview
    • 9.8.2. Key executives
    • 9.8.3. Company snapshot
    • 9.8.4. Operating business segments
    • 9.8.5. Product portfolio
    • 9.8.6. Business performance
    • 9.8.7. Key strategic moves and developments
  • 9.9. Eurofins Scientific SE
    • 9.9.1. Company overview
    • 9.9.2. Key executives
    • 9.9.3. Company snapshot
    • 9.9.4. Operating business segments
    • 9.9.5. Product portfolio
    • 9.9.6. Business performance
    • 9.9.7. Key strategic moves and developments
  • 9.10. Merck KGaA
    • 9.10.1. Company overview
    • 9.10.2. Key executives
    • 9.10.3. Company snapshot
    • 9.10.4. Operating business segments
    • 9.10.5. Product portfolio
    • 9.10.6. Business performance
    • 9.10.7. Key strategic moves and developments

LIST OF TABLES

  • TABLE 01. GLOBAL PYROGEN TESTING MARKET, BY PRODUCT AND SERVICE, 2022-2032 ($MILLION)
  • TABLE 02. PYROGEN TESTING MARKET FOR REAGENTS AND KITS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 03. PYROGEN TESTING MARKET FOR INSTRUMENTS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 04. PYROGEN TESTING MARKET FOR SERVICES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 05. GLOBAL PYROGEN TESTING MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 06. PYROGEN TESTING MARKET FOR LAL TEST, BY REGION, 2022-2032 ($MILLION)
  • TABLE 07. PYROGEN TESTING MARKET FOR RABBIT PYROGEN TEST, BY REGION, 2022-2032 ($MILLION)
  • TABLE 08. PYROGEN TESTING MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 09. GLOBAL PYROGEN TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 10. PYROGEN TESTING MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 11. PYROGEN TESTING MARKET FOR MEDICAL DEVICE COMPANIES, BY REGION, 2022-2032 ($MILLION)
  • TABLE 12. PYROGEN TESTING MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
  • TABLE 13. PYROGEN TESTING MARKET, BY REGION, 2022-2032 ($MILLION)
  • TABLE 14. NORTH AMERICA PYROGEN TESTING MARKET, BY PRODUCT AND SERVICE, 2022-2032 ($MILLION)
  • TABLE 15. NORTH AMERICA PYROGEN TESTING MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 16. NORTH AMERICA PYROGEN TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 17. NORTH AMERICA PYROGEN TESTING MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 18. U.S. PYROGEN TESTING MARKET, BY PRODUCT AND SERVICE, 2022-2032 ($MILLION)
  • TABLE 19. U.S. PYROGEN TESTING MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 20. U.S. PYROGEN TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 21. CANADA PYROGEN TESTING MARKET, BY PRODUCT AND SERVICE, 2022-2032 ($MILLION)
  • TABLE 22. CANADA PYROGEN TESTING MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 23. CANADA PYROGEN TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 24. MEXICO PYROGEN TESTING MARKET, BY PRODUCT AND SERVICE, 2022-2032 ($MILLION)
  • TABLE 25. MEXICO PYROGEN TESTING MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 26. MEXICO PYROGEN TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 27. EUROPE PYROGEN TESTING MARKET, BY PRODUCT AND SERVICE, 2022-2032 ($MILLION)
  • TABLE 28. EUROPE PYROGEN TESTING MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 29. EUROPE PYROGEN TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 30. EUROPE PYROGEN TESTING MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 31. GERMANY PYROGEN TESTING MARKET, BY PRODUCT AND SERVICE, 2022-2032 ($MILLION)
  • TABLE 32. GERMANY PYROGEN TESTING MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 33. GERMANY PYROGEN TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 34. FRANCE PYROGEN TESTING MARKET, BY PRODUCT AND SERVICE, 2022-2032 ($MILLION)
  • TABLE 35. FRANCE PYROGEN TESTING MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 36. FRANCE PYROGEN TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 37. UK PYROGEN TESTING MARKET, BY PRODUCT AND SERVICE, 2022-2032 ($MILLION)
  • TABLE 38. UK PYROGEN TESTING MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 39. UK PYROGEN TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 40. ITALY PYROGEN TESTING MARKET, BY PRODUCT AND SERVICE, 2022-2032 ($MILLION)
  • TABLE 41. ITALY PYROGEN TESTING MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 42. ITALY PYROGEN TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 43. SPAIN PYROGEN TESTING MARKET, BY PRODUCT AND SERVICE, 2022-2032 ($MILLION)
  • TABLE 44. SPAIN PYROGEN TESTING MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 45. SPAIN PYROGEN TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 46. REST OF EUROPE PYROGEN TESTING MARKET, BY PRODUCT AND SERVICE, 2022-2032 ($MILLION)
  • TABLE 47. REST OF EUROPE PYROGEN TESTING MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 48. REST OF EUROPE PYROGEN TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 49. ASIA-PACIFIC PYROGEN TESTING MARKET, BY PRODUCT AND SERVICE, 2022-2032 ($MILLION)
  • TABLE 50. ASIA-PACIFIC PYROGEN TESTING MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 51. ASIA-PACIFIC PYROGEN TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 52. ASIA-PACIFIC PYROGEN TESTING MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 53. JAPAN PYROGEN TESTING MARKET, BY PRODUCT AND SERVICE, 2022-2032 ($MILLION)
  • TABLE 54. JAPAN PYROGEN TESTING MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 55. JAPAN PYROGEN TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 56. CHINA PYROGEN TESTING MARKET, BY PRODUCT AND SERVICE, 2022-2032 ($MILLION)
  • TABLE 57. CHINA PYROGEN TESTING MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 58. CHINA PYROGEN TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 59. INDIA PYROGEN TESTING MARKET, BY PRODUCT AND SERVICE, 2022-2032 ($MILLION)
  • TABLE 60. INDIA PYROGEN TESTING MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 61. INDIA PYROGEN TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 62. AUSTRALIA PYROGEN TESTING MARKET, BY PRODUCT AND SERVICE, 2022-2032 ($MILLION)
  • TABLE 63. AUSTRALIA PYROGEN TESTING MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 64. AUSTRALIA PYROGEN TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 65. SOUTH KOREA PYROGEN TESTING MARKET, BY PRODUCT AND SERVICE, 2022-2032 ($MILLION)
  • TABLE 66. SOUTH KOREA PYROGEN TESTING MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 67. SOUTH KOREA PYROGEN TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 68. REST OF ASIA-PACIFIC PYROGEN TESTING MARKET, BY PRODUCT AND SERVICE, 2022-2032 ($MILLION)
  • TABLE 69. REST OF ASIA-PACIFIC PYROGEN TESTING MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 70. REST OF ASIA-PACIFIC PYROGEN TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 71. LATIN AMERICA PYROGEN TESTING MARKET, BY PRODUCT AND SERVICE, 2022-2032 ($MILLION)
  • TABLE 72. LATIN AMERICA PYROGEN TESTING MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 73. LATIN AMERICA PYROGEN TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 74. LATIN AMERICA PYROGEN TESTING MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 75. BRAZIL PYROGEN TESTING MARKET, BY PRODUCT AND SERVICE, 2022-2032 ($MILLION)
  • TABLE 76. BRAZIL PYROGEN TESTING MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 77. BRAZIL PYROGEN TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 78. COLOMBIA PYROGEN TESTING MARKET, BY PRODUCT AND SERVICE, 2022-2032 ($MILLION)
  • TABLE 79. COLOMBIA PYROGEN TESTING MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 80. COLOMBIA PYROGEN TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 81. ARGENTINA PYROGEN TESTING MARKET, BY PRODUCT AND SERVICE, 2022-2032 ($MILLION)
  • TABLE 82. ARGENTINA PYROGEN TESTING MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 83. ARGENTINA PYROGEN TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 84. REST OF LA PYROGEN TESTING MARKET, BY PRODUCT AND SERVICE, 2022-2032 ($MILLION)
  • TABLE 85. REST OF LA PYROGEN TESTING MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 86. REST OF LA PYROGEN TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 87. MIDDLE EAST AND AFRICA PYROGEN TESTING MARKET, BY PRODUCT AND SERVICE, 2022-2032 ($MILLION)
  • TABLE 88. MIDDLE EAST AND AFRICA PYROGEN TESTING MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 89. MIDDLE EAST AND AFRICA PYROGEN TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 90. MIDDLE EAST AND AFRICA PYROGEN TESTING MARKET, BY COUNTRY, 2022-2032 ($MILLION)
  • TABLE 91. GCC PYROGEN TESTING MARKET, BY PRODUCT AND SERVICE, 2022-2032 ($MILLION)
  • TABLE 92. GCC PYROGEN TESTING MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 93. GCC PYROGEN TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 94. SOUTH AFRICA PYROGEN TESTING MARKET, BY PRODUCT AND SERVICE, 2022-2032 ($MILLION)
  • TABLE 95. SOUTH AFRICA PYROGEN TESTING MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 96. SOUTH AFRICA PYROGEN TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 97. NORTH AFRICA PYROGEN TESTING MARKET, BY PRODUCT AND SERVICE, 2022-2032 ($MILLION)
  • TABLE 98. NORTH AFRICA PYROGEN TESTING MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 99. NORTH AFRICA PYROGEN TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 100. REST OF MEA PYROGEN TESTING MARKET, BY PRODUCT AND SERVICE, 2022-2032 ($MILLION)
  • TABLE 101. REST OF MEA PYROGEN TESTING MARKET, BY TEST TYPE, 2022-2032 ($MILLION)
  • TABLE 102. REST OF MEA PYROGEN TESTING MARKET, BY END USER, 2022-2032 ($MILLION)
  • TABLE 103. LONZA GROUP AG: KEY EXECUTIVES
  • TABLE 104. LONZA GROUP AG: COMPANY SNAPSHOT
  • TABLE 105. LONZA GROUP AG: PRODUCT SEGMENTS
  • TABLE 106. LONZA GROUP AG: SERVICE SEGMENTS
  • TABLE 107. LONZA GROUP AG: PRODUCT PORTFOLIO
  • TABLE 108. LONZA GROUP AG: KEY STRATERGIES
  • TABLE 109. THERMO FISHER SCIENTIFIC INC. : KEY EXECUTIVES
  • TABLE 110. THERMO FISHER SCIENTIFIC INC. : COMPANY SNAPSHOT
  • TABLE 111. THERMO FISHER SCIENTIFIC INC. : PRODUCT SEGMENTS
  • TABLE 112. THERMO FISHER SCIENTIFIC INC. : SERVICE SEGMENTS
  • TABLE 113. THERMO FISHER SCIENTIFIC INC. : PRODUCT PORTFOLIO
  • TABLE 114. THERMO FISHER SCIENTIFIC INC. : KEY STRATERGIES
  • TABLE 115. FUJIFILM HOLDINGS CORPORATION: KEY EXECUTIVES
  • TABLE 116. FUJIFILM HOLDINGS CORPORATION: COMPANY SNAPSHOT
  • TABLE 117. FUJIFILM HOLDINGS CORPORATION: PRODUCT SEGMENTS
  • TABLE 118. FUJIFILM HOLDINGS CORPORATION: SERVICE SEGMENTS
  • TABLE 119. FUJIFILM HOLDINGS CORPORATION: PRODUCT PORTFOLIO
  • TABLE 120. FUJIFILM HOLDINGS CORPORATION: KEY STRATERGIES
  • TABLE 121. GENSCRIPT: KEY EXECUTIVES
  • TABLE 122. GENSCRIPT: COMPANY SNAPSHOT
  • TABLE 123. GENSCRIPT: PRODUCT SEGMENTS
  • TABLE 124. GENSCRIPT: SERVICE SEGMENTS
  • TABLE 125. GENSCRIPT: PRODUCT PORTFOLIO
  • TABLE 126. GENSCRIPT: KEY STRATERGIES
  • TABLE 127. SEIKAGAKU CORPORATION: KEY EXECUTIVES
  • TABLE 128. SEIKAGAKU CORPORATION: COMPANY SNAPSHOT
  • TABLE 129. SEIKAGAKU CORPORATION: PRODUCT SEGMENTS
  • TABLE 130. SEIKAGAKU CORPORATION: SERVICE SEGMENTS
  • TABLE 131. SEIKAGAKU CORPORATION: PRODUCT PORTFOLIO
  • TABLE 132. SEIKAGAKU CORPORATION: KEY STRATERGIES
  • TABLE 133. CHARLES RIVER LABORATORIES: KEY EXECUTIVES
  • TABLE 134. CHARLES RIVER LABORATORIES: COMPANY SNAPSHOT
  • TABLE 135. CHARLES RIVER LABORATORIES: PRODUCT SEGMENTS
  • TABLE 136. CHARLES RIVER LABORATORIES: SERVICE SEGMENTS
  • TABLE 137. CHARLES RIVER LABORATORIES: PRODUCT PORTFOLIO
  • TABLE 138. CHARLES RIVER LABORATORIES: KEY STRATERGIES
  • TABLE 139. STERIS PLC: KEY EXECUTIVES
  • TABLE 140. STERIS PLC: COMPANY SNAPSHOT
  • TABLE 141. STERIS PLC: PRODUCT SEGMENTS
  • TABLE 142. STERIS PLC: SERVICE SEGMENTS
  • TABLE 143. STERIS PLC: PRODUCT PORTFOLIO
  • TABLE 144. STERIS PLC: KEY STRATERGIES
  • TABLE 145. WUXI APPTEC: KEY EXECUTIVES
  • TABLE 146. WUXI APPTEC: COMPANY SNAPSHOT
  • TABLE 147. WUXI APPTEC: PRODUCT SEGMENTS
  • TABLE 148. WUXI APPTEC: SERVICE SEGMENTS
  • TABLE 149. WUXI APPTEC: PRODUCT PORTFOLIO
  • TABLE 150. WUXI APPTEC: KEY STRATERGIES
  • TABLE 151. EUROFINS SCIENTIFIC SE: KEY EXECUTIVES
  • TABLE 152. EUROFINS SCIENTIFIC SE: COMPANY SNAPSHOT
  • TABLE 153. EUROFINS SCIENTIFIC SE: PRODUCT SEGMENTS
  • TABLE 154. EUROFINS SCIENTIFIC SE: SERVICE SEGMENTS
  • TABLE 155. EUROFINS SCIENTIFIC SE: PRODUCT PORTFOLIO
  • TABLE 156. EUROFINS SCIENTIFIC SE: KEY STRATERGIES
  • TABLE 157. MERCK KGAA: KEY EXECUTIVES
  • TABLE 158. MERCK KGAA: COMPANY SNAPSHOT
  • TABLE 159. MERCK KGAA: PRODUCT SEGMENTS
  • TABLE 160. MERCK KGAA: SERVICE SEGMENTS
  • TABLE 161. MERCK KGAA: PRODUCT PORTFOLIO
  • TABLE 162. MERCK KGAA: KEY STRATERGIES

LIST OF FIGURES

  • FIGURE 01. PYROGEN TESTING MARKET, 2022-2032
  • FIGURE 02. SEGMENTATION OF PYROGEN TESTING MARKET,2022-2032
  • FIGURE 03. TOP IMPACTING FACTORS IN PYROGEN TESTING MARKET
  • FIGURE 04. TOP INVESTMENT POCKETS IN PYROGEN TESTING MARKET (2023-2032)
  • FIGURE 05. LOW BARGAINING POWER OF SUPPLIERS
  • FIGURE 06. LOW THREAT OF NEW ENTRANTS
  • FIGURE 07. LOW THREAT OF SUBSTITUTES
  • FIGURE 08. LOW INTENSITY OF RIVALRY
  • FIGURE 09. LOW BARGAINING POWER OF BUYERS
  • FIGURE 10. GLOBAL PYROGEN TESTING MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
  • FIGURE 11. PYROGEN TESTING MARKET, BY PRODUCT AND SERVICE, 2022 AND 2032(%)
  • FIGURE 12. COMPARATIVE SHARE ANALYSIS OF PYROGEN TESTING MARKET FOR REAGENTS AND KITS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 13. COMPARATIVE SHARE ANALYSIS OF PYROGEN TESTING MARKET FOR INSTRUMENTS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 14. COMPARATIVE SHARE ANALYSIS OF PYROGEN TESTING MARKET FOR SERVICES, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 15. PYROGEN TESTING MARKET, BY TEST TYPE, 2022 AND 2032(%)
  • FIGURE 16. COMPARATIVE SHARE ANALYSIS OF PYROGEN TESTING MARKET FOR LAL TEST, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 17. COMPARATIVE SHARE ANALYSIS OF PYROGEN TESTING MARKET FOR RABBIT PYROGEN TEST, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 18. COMPARATIVE SHARE ANALYSIS OF PYROGEN TESTING MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 19. PYROGEN TESTING MARKET, BY END USER, 2022 AND 2032(%)
  • FIGURE 20. COMPARATIVE SHARE ANALYSIS OF PYROGEN TESTING MARKET FOR PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 21. COMPARATIVE SHARE ANALYSIS OF PYROGEN TESTING MARKET FOR MEDICAL DEVICE COMPANIES, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 22. COMPARATIVE SHARE ANALYSIS OF PYROGEN TESTING MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)
  • FIGURE 23. PYROGEN TESTING MARKET BY REGION, 2022 AND 2032(%)
  • FIGURE 24. U.S. PYROGEN TESTING MARKET, 2022-2032 ($MILLION)
  • FIGURE 25. CANADA PYROGEN TESTING MARKET, 2022-2032 ($MILLION)
  • FIGURE 26. MEXICO PYROGEN TESTING MARKET, 2022-2032 ($MILLION)
  • FIGURE 27. GERMANY PYROGEN TESTING MARKET, 2022-2032 ($MILLION)
  • FIGURE 28. FRANCE PYROGEN TESTING MARKET, 2022-2032 ($MILLION)
  • FIGURE 29. UK PYROGEN TESTING MARKET, 2022-2032 ($MILLION)
  • FIGURE 30. ITALY PYROGEN TESTING MARKET, 2022-2032 ($MILLION)
  • FIGURE 31. SPAIN PYROGEN TESTING MARKET, 2022-2032 ($MILLION)
  • FIGURE 32. REST OF EUROPE PYROGEN TESTING MARKET, 2022-2032 ($MILLION)
  • FIGURE 33. JAPAN PYROGEN TESTING MARKET, 2022-2032 ($MILLION)
  • FIGURE 34. CHINA PYROGEN TESTING MARKET, 2022-2032 ($MILLION)
  • FIGURE 35. INDIA PYROGEN TESTING MARKET, 2022-2032 ($MILLION)
  • FIGURE 36. AUSTRALIA PYROGEN TESTING MARKET, 2022-2032 ($MILLION)
  • FIGURE 37. SOUTH KOREA PYROGEN TESTING MARKET, 2022-2032 ($MILLION)
  • FIGURE 38. REST OF ASIA-PACIFIC PYROGEN TESTING MARKET, 2022-2032 ($MILLION)
  • FIGURE 39. BRAZIL PYROGEN TESTING MARKET, 2022-2032 ($MILLION)
  • FIGURE 40. COLOMBIA PYROGEN TESTING MARKET, 2022-2032 ($MILLION)
  • FIGURE 41. ARGENTINA PYROGEN TESTING MARKET, 2022-2032 ($MILLION)
  • FIGURE 42. REST OF LA PYROGEN TESTING MARKET, 2022-2032 ($MILLION)
  • FIGURE 43. GCC PYROGEN TESTING MARKET, 2022-2032 ($MILLION)
  • FIGURE 44. SOUTH AFRICA PYROGEN TESTING MARKET, 2022-2032 ($MILLION)
  • FIGURE 45. NORTH AFRICA PYROGEN TESTING MARKET, 2022-2032 ($MILLION)
  • FIGURE 46. REST OF MEA PYROGEN TESTING MARKET, 2022-2032 ($MILLION)
  • FIGURE 47. TOP WINNING STRATEGIES, BY YEAR
  • FIGURE 48. TOP WINNING STRATEGIES, BY DEVELOPMENT
  • FIGURE 49. TOP WINNING STRATEGIES, BY COMPANY
  • FIGURE 50. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 51. COMPETITIVE DASHBOARD
  • FIGURE 52. COMPETITIVE HEATMAP: PYROGEN TESTING MARKET
  • FIGURE 53. TOP PLAYER POSITIONING, 2022